Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to 9.95%.

  • Rockwell Medical's EBIT Margin fell 167800.0% to 9.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.37%, marking a year-over-year decrease of 69500.0%. This contributed to the annual value of 0.6% for FY2024, which is 85800.0% up from last year.
  • Per Rockwell Medical's latest filing, its EBIT Margin stood at 9.95% for Q3 2025, which was down 167800.0% from 8.39% recorded in Q2 2025.
  • Rockwell Medical's 5-year EBIT Margin high stood at 6.84% for Q3 2024, and its period low was 54.52% during Q4 2021.
  • In the last 5 years, Rockwell Medical's EBIT Margin had a median value of 9.95% in 2025 and averaged 18.39%.
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 443400bps in 2022, then plummeted by -167800bps in 2025.
  • Rockwell Medical's EBIT Margin (Quarter) stood at 54.52% in 2021, then skyrocketed by 81bps to 10.18% in 2022, then skyrocketed by 76bps to 2.48% in 2023, then increased by 15bps to 2.1% in 2024, then tumbled by -373bps to 9.95% in 2025.
  • Its EBIT Margin stands at 9.95% for Q3 2025, versus 8.39% for Q2 2025 and 7.19% for Q1 2025.